Author Bios



G. Daniel Grass, MD, PhD; Matthew N. Mills, MD; Jacob G. Scott, MD, DPhil; Steven A. Eschrich, PhD; Javier Torres-Roca, MD

G. Daniel Grass, MD, PhD; Matthew N. Mills, MD; Jacob G. Scott, MD, DPhil; Steven A. Eschrich, PhD; Javier Torres-Roca, MD

Dr. Grass is an assistant member and Dr. Mills is a radiation oncology resident, Department of Radiation Oncology, Lee Moffitt Cancer Center and Research Institute, Tampa, FL. Dr. Scott is an assistant professor, Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH. Dr. Eschrich is a senior member, Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute. Dr. Torres-Roca is a senior member, Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute. Disclosure: Drs. Scott, Torres-Roca and Eschrich report intellectual property (IP); Drs. Scott and Torres-Roca report IP regarding genomically adjusted radiation dose (GARD), and Drs. Eschrich and Torres-Roca report stock in Cvergenx. None of the authors received outside funding for the production of this original manuscript and no part of this article has been previously published elsewhere.

Articles Written

Copyright © Anderson Publishing, Ltd

 2021
    Agility CMS